APA (7th ed.) Citation

RV, O., SØ, L., & D, T. (2019). Impact on HbA1c and body weight of switching from other GLP-1 receptor agonists to semaglutide: A model-based approach. Diabetes, obesity & metabolism, 21(1), 43. https://doi.org/10.1111/dom.13479

Chicago Style (17th ed.) Citation

RV, Overgaard, Lindberg SØ, and Thielke D. "Impact on HbA1c and Body Weight of Switching from Other GLP-1 Receptor Agonists to Semaglutide: A Model-based Approach." Diabetes, Obesity & Metabolism 21, no. 1 (2019): 43. https://doi.org/10.1111/dom.13479.

MLA (9th ed.) Citation

RV, Overgaard, et al. "Impact on HbA1c and Body Weight of Switching from Other GLP-1 Receptor Agonists to Semaglutide: A Model-based Approach." Diabetes, Obesity & Metabolism, vol. 21, no. 1, 2019, p. 43, https://doi.org/10.1111/dom.13479.